...
hoth-img

Hoth Therapeutics Inc, Common Stock

HOTH

NAQ

$0.8366

+$0

(0%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.81M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
92.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.84
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.58 L
$1.73 H
$0.8366

About Hoth Therapeutics Inc, Common Stock

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; and HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameHOTHSectorS&P500
1-Week Return-0.4%-2.12%0.77%
1-Month Return-5.04%-2.54%2.65%
3-Month Return-21.08%-6.28%12.3%
6-Month Return-25.96%-1.36%13.48%
1-Year Return-32.53%9.29%33.47%
3-Year Return-95.47%10.05%32.22%
5-Year Return-99.24%43.69%92.85%
10-Year Return-99.61%103.1%194.31%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue31.62K25.87K46.87M66.83K-[{"date":"2019-12-31","value":0.07,"profit":true},{"date":"2020-12-31","value":0.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.14,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit(31.62K)(25.87K)(46.87M)(66.83K)-[{"date":"2019-12-31","value":-3162200,"profit":false},{"date":"2020-12-31","value":-2587100,"profit":false},{"date":"2021-12-31","value":-4687100000,"profit":false},{"date":"2022-12-31","value":-6683400,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)-[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses7.71M7.30M14.10M11.07M7.69M[{"date":"2019-12-31","value":54.71,"profit":true},{"date":"2020-12-31","value":51.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.47,"profit":true},{"date":"2023-12-31","value":54.55,"profit":true}]
Operating Income(7.71M)(7.30M)(14.10M)(11.07M)(7.69M)[{"date":"2019-12-31","value":-771499700,"profit":false},{"date":"2020-12-31","value":-730197400,"profit":false},{"date":"2021-12-31","value":-1410144000,"profit":false},{"date":"2022-12-31","value":-1106555400,"profit":false},{"date":"2023-12-31","value":-769224200,"profit":false}]
Total Non-Operating Income/Expense10.39K-(212.26K)(300.03K)(152.37K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2043.76,"profit":false},{"date":"2022-12-31","value":-2888.78,"profit":false},{"date":"2023-12-31","value":-1467.04,"profit":false}]
Pre-Tax Income(7.70M)(7.20M)(14.31M)(11.37M)(7.85M)[{"date":"2019-12-31","value":-770463600,"profit":false},{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1137195300,"profit":false},{"date":"2023-12-31","value":-784539000,"profit":false}]
Income Taxes(10.36K)(205.25K)212.26K305.41K(7.69K)[{"date":"2019-12-31","value":-3.39,"profit":false},{"date":"2020-12-31","value":-67.21,"profit":false},{"date":"2021-12-31","value":69.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.52,"profit":false}]
Income After Taxes(7.69M)-(14.53M)(11.68M)(7.84M)[{"date":"2019-12-31","value":-769427500,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1452597000,"profit":false},{"date":"2022-12-31","value":-1167736200,"profit":false},{"date":"2023-12-31","value":-783769776,"profit":false}]
Income From Continuous Operations(7.70M)(7.20M)(14.31M)(11.37M)(9.62M)[{"date":"2019-12-31","value":-770463600,"profit":false},{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1137195300,"profit":false},{"date":"2023-12-31","value":-962174300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.69M)(7.20M)(14.31M)(11.68M)(7.85M)[{"date":"2019-12-31","value":-769427500,"profit":false},{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1167736200,"profit":false},{"date":"2023-12-31","value":-784539000,"profit":false}]
EPS (Diluted)(18.11)(14.50)(16.50)(9.91)(4.35)[{"date":"2019-12-31","value":-1811,"profit":false},{"date":"2020-12-31","value":-1450,"profit":false},{"date":"2021-12-31","value":-1650,"profit":false},{"date":"2022-12-31","value":-991,"profit":false},{"date":"2023-12-31","value":-434.72,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HOTH
Cash Ratio 9.90
Current Ratio 10.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HOTH
ROA (LTM) -46.16%
ROE (LTM) -83.41%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HOTH
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HOTH
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.77
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.40

FAQs

What is Hoth Therapeutics Inc share price today?

Hoth Therapeutics Inc (HOTH) share price today is $0.8366

Can Indians buy Hoth Therapeutics Inc shares?

Yes, Indians can buy shares of Hoth Therapeutics Inc (HOTH) on Vested. To buy Hoth Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HOTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hoth Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Hoth Therapeutics Inc (HOTH) via the Vested app. You can start investing in Hoth Therapeutics Inc (HOTH) with a minimum investment of $1.

How to invest in Hoth Therapeutics Inc shares from India?

You can invest in shares of Hoth Therapeutics Inc (HOTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in HOTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hoth Therapeutics Inc shares
What is Hoth Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Hoth Therapeutics Inc (HOTH) is $1.73. The 52-week low price of Hoth Therapeutics Inc (HOTH) is $0.58.

What is Hoth Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Hoth Therapeutics Inc (HOTH) is

What is Hoth Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hoth Therapeutics Inc (HOTH) is 0.77

What is Hoth Therapeutics Inc dividend yield?

The dividend yield of Hoth Therapeutics Inc (HOTH) is 0.00%

What is the Market Cap of Hoth Therapeutics Inc?

The market capitalization of Hoth Therapeutics Inc (HOTH) is $5.81M

What is Hoth Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Hoth Therapeutics Inc is HOTH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top